17. Prehospital Tranexamic Acid for Severe Trauma

What was the primary outcome measured in the study on tranexamic acid for severe trauma?

True or False: Tranexamic acid significantly improved long-term functional outcomes in trauma patients.

What percentage of patients in the tranexamic acid group survived with a favorable functional outcome at six months?

What was the main cause of preventable trauma deaths addressed by tranexamic acid?

True or False: The study found no significant difference in early mortality between tranexamic acid and placebo.

Which trial previously demonstrated the benefit of tranexamic acid in reducing mortality in trauma patients?

Which Glasgow Outcome Scale–Extended (GOS-E) score range indicated survival with a favorable functional outcome?

What factor was associated with a higher risk of mortality in the study?

True or False: Tranexamic acid reduced the number of thromboembolic events in trauma patients.

Which country was NOT involved in the PATCH-Trauma trial?

What was the COAST score used for in the study?

True or False: Tranexamic acid was administered as a bolus dose followed by an infusion.

What was the primary method used to assess long-term functional outcomes in the trial?

What percentage of patients in the placebo group survived with a favorable functional outcome at 6 months?

What was the median time from injury to first dose of tranexamic acid in the study?